| Institution: | 1. Department of Dermatology, UMass Chan Medical School, Worcester, Massachusetts, USA;2. Division of Rheumatology & Immunology, College of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA;3. Department of Dermatology, Yokohama City University Graduate School of Medicine, Yokohama, Japan;4. Department of Dermatology, UT Southwestern Medical Center, Dallas, Texas, USA;5. Department of Biomedical Data Science, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire, USA;6. Department of Molecular and Systems Biology, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire, USA;7. Department of Medicine, University of Pittsburg School of Medicine, Pittsburg, Pennsylvania, USA;8. Department of Pathology, UMass Chan Medical School, Worcester, Massachusetts, USA;9. ProPath, Dallas, Texas, USA;1. Dermatology Hospital, Southern Medical University, Guangzhou, China;2. Cancer Research Institute, School of Basic Medical Sciences, State Key Laboratory of Organ Failure Research, National Clinical Research Center of Kidney Disease, Key Laboratory of Organ Failure Research (Ministry of Education), Southern Medical University, Guangzhou, China;1. Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden;1. Department of Molecular Medicine and Pathology, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand;2. Maurice Wilkins Centre for Molecular Biodiscovery, Hosted by the University of Auckland, Auckland, New Zealand;3. Department of Oncology, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand;4. Auckland Cancer Society Research Centre, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand;1. Department of Dermatology, Boston University School of Medicine, Boston, Massachusetts, USA;2. Centre for Skin Sciences, School of Chemistry and Biosciences, University of Bradford, West Yorkshire, United Kingdom;1. Department of Dermatology, Yale School of Medicine, New Haven, Connecticut, USA;1. Dermatology Department, CHU Bordeaux, Bordeaux, France;2. Bordeaux Institute of Oncology, BRIC U1312, INSERM, Team 5 Translational Research on Oncodermatology and Rare Skin Diseases, Univ. Bordeaux, Bordeaux, France;3. Department of Tumor Biology, CHU Bordeaux, Pessac, France |
